New: companion diagnostics

Learn more
About us

Finding innovative

OMICS solutions

OHMX.bio provides a complete R&D platform to help our customers resolve their biological questions through cutting-edge technology in different –omics fields. We provide start-to-finish project management from sample preparation to customized data analysis and data reporting possibilities to the global research community in the field of transcriptomics, translatomics, proteomics and (epi)genetics. Novel approaches are constantly evaluated and incorporated into our service portfolio. Our projects are collaborations between an experienced team of wet-lab scientists, bioinformaticians and complementing expert profiles in order to bring the best solutions forward.

 

We are a Belgian company founded in Ghent in 2019, as a spin-off initiative of Ghent University. We profit from academic expertise in high throughput analysis methods. We meet the high demand for specialized technologies to measure different -omics levels and their distinct modifications (DNA/RNA epigenetics and post-translational modifications).

 

We offer state-of-the-art solutions to aid our customers to provide these genome-wide maps, built on the latest sequencing (Illumina and Oxford Nanopore) and mass spectrometry technologies. Currently, we focus on unravelling genome-wide maps of translated mRNA, a technique called ribosome profiling or RIBO-seq. We constantly develop our service portfolio using novel technologies as currently the direct DNA and RNA sequencing using the Oxford Nanopore Technology and single-cell transcriptomics solutions (e.g. 10x genomics) in close collaboration with our academic experts.

Our team

Our team

Gerben Menschaert

CSO & Co-founder

Prof. Gerben Menschaert is the CSO and co-founder of OHMX.bio. He is an expert in high-throughput technologies (sequencing and mass spectrometry) and bioinformatics. After working for several years in both pharmaceutical and biotech companies (Janssen Pharmaceutica & deVGen) he built an academic career (Belgium, US, Australia). As CSO, he steers the OHMX.bio team.

Katrien Vanhonacker

Director of business development CDx

More than 25y experience in both global operating life sciences multinationals as well as scale-ups. Commercial track record in diagnostics and multi-omics field. Background in biotechnology and business education. Passionate about therapeutics enabling technologies and big data.

Hendrik Van de Voorde

COO

Hendrik Van de Voorde is the operations manager at OHMX.bio. He has over 10 years of experience working in medical genetics with specific expertise in biomarker discovery and the implementation of novel epigentic technology. At OHMX.bio he is responsible for operations and oversees the design and execution of our full range of services.

Adriaan Verhelle

Business developer

Dr. Adriaan Verhelle has a strong background in human genetics and molecular biology. After finishing his Ph.D in Biomedical Sciences at Ghent University he moved to the US for his postdoctoral studies in neuroscience at Scripps Research institute. At OHMX.bio he is responsible for developing and maintaining customer relationships with clients.

Karolien De Kimpe

R&D scientist & QMS manager

Karolien De Kimpe is experienced in Human genetics, next generation sequencing and has a growing experience in third-generation sequencing. At OHMX.bio she manages wet lab projects and is responsible for implementing and maintaining the Information Security Management System (ISO2700) and Quality Management System (ISO 9001).

Anna Matsaroki

R&D scientist & project manager

Anna Matsaroki is the R&D scientist and Project leader at OHMX.bio. She is highly experienced in sequencing services with a main focus on epigenomics and transcriptomics. As a project manager, she is responsible for the project design and the wet lab procedures.

Steven Verbruggen

Senior bioinformatician

Dr. Steven Verbruggen is a bioscience engineer specialized in bioinformatics for high-throughput technologies (sequencing and mass spectrometry). In his Ph.D, he focused on the development of bioinformatic tools for multi-omic research. As a senior bioinformatician, he is responsible for all data science solutions within OHMX.bio.

Arne Godderis

Junior bioinformatician

Iuliana Vintea

Doctoral researcher

Iuliana is a bioscience engineer specialized in cell and gene technology. Her focus now is on cancer research where she aims to develop a clinical diagnostic test to predict ferroptosis sensitivity based on Oxford Nanopore Sequencing.

Advisors

Advisors

Wim Van Criekinge

Scientific advisor

Prof. Wim Van Criekinge, together with Jan, is a co-founder of the Novalis Biotech Incubation. He is a tenured professor at the University of Gent with an interest in the use of machine learning in computational biology and bioinformatics.

Jan Van den Berghe

Business advisor

Jan Van den Berghe is a serial entrepreneur in the biotech industry, co-founding the Novalis biotech incubation together with Wim. He has co-founded and served as director for several successful biotech startups that have been acquired by leading healthcare and life science companies.

Success stories

Success stories

First story

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc eu risus vel lorem aliquam pulvinar. Cras a purus diam. Nam ornare magna nec neque ullamcorper elementum faucibus in nisi. Suspendisse quis semper augue.

Second story

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc eu risus vel lorem aliquam pulvinar. Cras a purus diam. Nam ornare magna nec neque ullamcorper elementum faucibus in nisi. Suspendisse quis semper augue.

Third story

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc eu risus vel lorem aliquam pulvinar. Cras a purus diam. Nam ornare magna nec neque ullamcorper elementum faucibus in nisi. Suspendisse quis semper augue.

Partners
Partners
Find us

Find us
Work with us

Work with us

Business Developer

Research Scientist

Apply spontaneously